From Exotics to EU-GMP: PHCANN CEO Sasho Stefanoski on the future of European Cannabis
PHCANN CEO Sasho Stefanoski explores Europe’s medical cannabis transformation, from pioneering exotic genetics and EU-GMP innovation to global partnerships, patient access, and building a sustainable, credible industry that blends pharmaceutical rigor with cultural authenticity.
